Severe Acute Respiratory Syndrome Coronavirus 2 Clinical Trial
— COVID-19_EITOfficial title:
The Effect of Prone Positioning on Lung Aeration and Ventilation-perfusion Matching in Mechanically Ventilated Patients With Coronavirus Disease Related Acute Respiratory Distress Syndrome
NCT number | NCT04359407 |
Other study ID # | 2020-00896 |
Secondary ID | |
Status | Completed |
Phase | |
First received | |
Last updated | |
Start date | April 27, 2020 |
Est. completion date | May 10, 2021 |
Verified date | July 2021 |
Source | University Hospital, Geneva |
Contact | n/a |
Is FDA regulated | No |
Health authority | |
Study type | Observational |
The consensus therapeutic strategy implies that COVID patients with acute lung injury due to coronavirus are routinely placed in prone position in an attempt to improve oxygenation by increasing ventilation homogeneity. The purpose of the study is to quantify with the electrical impedance tomography (EIT) the changes in the ventilation and aeration in the dorsal regions of the lung when the patient is placed in prone position.
Status | Completed |
Enrollment | 29 |
Est. completion date | May 10, 2021 |
Est. primary completion date | May 10, 2021 |
Accepts healthy volunteers | No |
Gender | All |
Age group | 18 Years to 80 Years |
Eligibility | Inclusion Criteria: Patients fulfilling all the following criteria are eligible for the study: - Mechanically ventilated - Fit the Berlin Definition for moderate or severe acute respiratory distress syndrome (arterial oxygen partial pressure over inspiratory fraction of oxygen less than 200 mmHg) - Infection with coronavirus confirmed - Scheduled to undergo prone positioning Exclusion Criteria: - Patients with pacemakers, defibrillators or other electrically active implants - Patients with damaged skin or impaired skin contact of the electrodes due to wound dressings - Patients with chest tubes - History of thoracic surgery or lung resection |
Country | Name | City | State |
---|---|---|---|
Switzerland | University Hospitals of Geneva | Geneva |
Lead Sponsor | Collaborator |
---|---|
Walid HABRE |
Switzerland,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | Tidal electrical Impedance | Change in the ratio of tidal electrical impedance variation in the dorsal and total lung areas | One hour before turning to prone or supine positioning | |
Secondary | Intrapulmonary shunt | Changes in intrapulmonary shunt fraction | One hour before turning to prone or supine positioning | |
Secondary | Volumetric capnography | Changes in the phase three slope of the volumetric capnogram | One hour before turning to prone or supine positioning |
Status | Clinical Trial | Phase | |
---|---|---|---|
Recruiting |
NCT05543616 -
A Study to Learn About Variant-Adapted COVID-19 RNA Vaccine Candidate(s) in Healthy Children
|
Phase 2/Phase 3 | |
Recruiting |
NCT04516811 -
Therapeutic Use of Convalescent Plasma in the Treatment of Patients With Moderate to Severe COVID-19
|
Phase 3 | |
Completed |
NCT04334044 -
Treatment of SARS Caused by COVID-19 With Ruxolitinib
|
Phase 1/Phase 2 | |
Terminated |
NCT04371978 -
Efficacy and Safety of Dipeptidyl Peptidase-4 Inhibitors in Diabetic Patients With Established COVID-19
|
Phase 3 | |
Recruiting |
NCT04466241 -
Combination Therapies to Reduce Carriage of SARS-Cov-2 and Improve Outcome of COVID-19 in Ivory Coast: a Phase Randomized IIb Trial
|
Phase 2/Phase 3 | |
Withdrawn |
NCT04381923 -
COVIDNOCHE Trial (HFNO Versus CPAP Helmet) in COVID-19 Pneumonia
|
N/A | |
Recruiting |
NCT04402879 -
CORONA (COvid pRONe hypoxemiA): Prone Positioning for Hypoxemic COVID-19 Patients With Do-not-intubate Goals
|
N/A | |
Recruiting |
NCT04661631 -
Surgery and Lung Ultrasound in COVID-19 Infection
|
||
Completed |
NCT04376476 -
Host-pathogen Interactions During SARS-CoV-2 Infection
|
N/A | |
Completed |
NCT04375098 -
Efficacy and Safety of Early COVID-19 Convalescent Plasma in Patients Admitted for COVID-19 Infection
|
Phase 2 | |
Completed |
NCT04402060 -
A Study of APL-9 in Adults With Mild to Moderate ARDS Due to COVID-19
|
Phase 1/Phase 2 | |
Active, not recruiting |
NCT04365101 -
Natural Killer Cell (CYNK-001) Infusions in Adults With COVID-19
|
Phase 1/Phase 2 | |
Completed |
NCT04354779 -
Antibody Seroprevalence and Rate of Asymptomatic Infections With SARS-CoV-2 in Austrian Hospital Personnel.
|
||
Recruiting |
NCT04367207 -
African Covid-19 Critical Care Outcomes Study
|
||
Terminated |
NCT04409873 -
Antiseptic Mouthwash / Pre-Procedural Rinse on SARS-CoV-2 Load (COVID-19)
|
Phase 2 | |
Completed |
NCT04602351 -
Communication in ICU During COVID-19
|
||
Terminated |
NCT04707703 -
Isavuconazole for the Prevention of COVID-19-associated Pulmonary Aspergillosis
|
Phase 3 | |
Active, not recruiting |
NCT04987528 -
Pulmonary Fibrosis During Severe COVID-19 Pneumonia
|
||
Completed |
NCT04667936 -
Evaluation of Sedation in COVID-19 ARDS
|
||
Completed |
NCT04423770 -
COVID-19 Related Health and Infection Control Practices Among Dentists
|